Targeting the Serum Marker Interleukin 9 Improves the Underlying Characterization and Immune Homeostasis in Rheumatoid Arthritis

Overview

Journal Cent Eur J Immunol

Publisher Termedia

Specialty Allergy & Immunology

Date 2024 Oct 9

PMID 39381556

Authors

Ying Xiong

Wang Xiang

Wei Xiao

Affiliations

Soon will be listed here.

Abstract

Introduction: Rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPA) are serological markers used for diagnosing rheumatoid arthritis (RA), an autoimmune disease characterized by inflammatory joint damage. However, there is a subset of RA patients who test negative for both RF and ACPA, known as seronegative rheumatoid arthritis (SNRA).

Material And Methods: The levels of serum markers were examined in both clinical samples and a rat model of type II collagen-induced RA (CIA). The effect of interleukin 9 (IL-9) on RA was investigated using recombinant rat IL-9 (rrIL-9), anti-rat IL-9 neutralizing monoclonal antibody (mAb), and control IgG antibody in the CIA rat. The severity of arthritis was assessed. Treg and Th17 cells, M1 and M2 macrophages, and inflammatory cytokine levels were analyzed.

Results: We observed higher levels of IL-9 in clinical samples from SNRA patients compared to the normal group. Rat models of CIA exhibit increased arthritis scores, weight loss, paw swelling, and severe joint damage. IL-9 was the most sensitive serum marker for the diagnosis of RA in serum assays of CIA rats. IL-9 increased arthritis scores and cartilage damage, whereas treatment with IL-9 inhibitors produced the opposite effect. IL-9 inhibitors promoted Treg/Th17 homeostasis, decreased M1 macrophages, increased M2 macrophages, and decreased levels of inflammatory cytokines in joint tissues.

Conclusions: These results suggest that IL-9 has potential as a diagnostic marker for SNRA. Inhibition of IL-9 could reduce the severity of arthritis in CIA rats by ameliorating inflammation and modulating the Treg/Th17 immune balance, M2 and M1 macrophage activation.

References

Hughes-Austin J, Deane K, Derber L, Kolfenbach J, Zerbe G, Sokolove J . Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis. 2012; 72(6):901-7. PMC: 3726193. DOI: 10.1136/annrheumdis-2012-201505. View

Chakraborty S, Kubatzky K, Mitra D . An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis. Int J Mol Sci. 2019; 20(9). PMC: 6522352. DOI: 10.3390/ijms20092113. View

Heim J, Almanzar G, Schmalzing M, Gernert M, Tony H, Prelog M . Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions. Front Immunol. 2021; 12:668095. PMC: 8117786. DOI: 10.3389/fimmu.2021.668095. View

Elyaman W, Bradshaw E, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J . IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A. 2009; 106(31):12885-90. PMC: 2722314. DOI: 10.1073/pnas.0812530106. View

Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T . Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat Med. 2017; 23(8):938-944. PMC: 5575995. DOI: 10.1038/nm.4373. View

Trier N, Houen G . Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis. Expert Rev Mol Diagn. 2023; 23(10):895-911. DOI: 10.1080/14737159.2023.2247986. View

Triguero-Martinez A, de la Fuente H, Montes N, Ortiz A, Roy-Vallejo E, Castaneda S . Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis. Sci Rep. 2020; 10(1):17799. PMC: 7576119. DOI: 10.1038/s41598-020-74185-8. View

Sparks J . Rheumatoid Arthritis. Ann Intern Med. 2019; 170(1):ITC1-ITC16. DOI: 10.7326/AITC201901010. View

Gravallese E, Firestein G . Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N Engl J Med. 2023; 388(6):529-542. DOI: 10.1056/NEJMra2103726. View

10.

Hu F, Jiang X, Guo C, Li Y, Chen S, Zhang W . Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study. Nat Commun. 2020; 11(1):1911. PMC: 7171100. DOI: 10.1038/s41467-020-15700-3. View

11.

Nowak E, Weaver C, Turner H, Begum-Haque S, Becher B, Schreiner B . IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med. 2009; 206(8):1653-60. PMC: 2722185. DOI: 10.1084/jem.20090246. View

12.

Chen Z, Bozec A, Ramming A, Schett G . Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2018; 15(1):9-17. DOI: 10.1038/s41584-018-0109-2. View

13.

Ciccia F, Guggino G, Rizzo A, Manzo A, Vitolo B, La Manna M . Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2015; 54(12):2264-72. DOI: 10.1093/rheumatology/kev252. View

14.

Despres N, Boire G, Lopez-Longo F, Menard H . The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol. 1994; 21(6):1027-33. View

15.

Zhu Y, Zhang L, Zhang X, Wu D, Chen L, Hu C . Tripterygium wilfordii glycosides ameliorates collagen-induced arthritis and aberrant lipid metabolism in rats. Front Pharmacol. 2022; 13:938849. PMC: 9465305. DOI: 10.3389/fphar.2022.938849. View

16.

Cutolo M, Campitiello R, Gotelli E, Soldano S . The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. Front Immunol. 2022; 13:867260. PMC: 9161083. DOI: 10.3389/fimmu.2022.867260. View

17.

Dong C . Cytokine Regulation and Function in T Cells. Annu Rev Immunol. 2021; 39:51-76. DOI: 10.1146/annurev-immunol-061020-053702. View

18.

Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H . Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 2010; 62(10):2876-85. DOI: 10.1002/art.27622. View

19.

Deng Y, Wang Z, Chang C, Lu L, Lau C, Lu Q . Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials. Hum Immunol. 2017; 78(2):120-128. DOI: 10.1016/j.humimm.2016.12.010. View

20.

Dantas A, Lopes Marques C, da Rocha Junior L, Brayner Cavalcanti M, Goncalves S, Cardoso P . Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?. Dis Markers. 2015; 2015:519638. PMC: 4452366. DOI: 10.1155/2015/519638. View